Limoneira CO

Insider Buying Week 01-09-26

by

Whatever I write up here stands the chance of being obsolete by the weekend with Limelightin lovin Trump.  But when the headlines die down and you drift back to the business logic, it’s insiders that carry the water more often than not. So when the hell and furry settle, you’ll ask yourself what did Trump say that was full of sound and fury, signifying nothing, ? Go back and look at the insider trades Name: David M. Boitano Position: EVP & CIO Transaction Date: 12-31-2025  Shares Bought: 10,000 shares an Average Price Paid of $34.44 for Cost: $344,400 Company: LTC … Read more

$KERN and other Zombies Insider Buying week 10-15-21

by

Curious how well insiders are doing with their buys? Click on this link or image above to scroll the significant buys of the last year. You think there can’t get any less insider buying but it gets worse this week. As much as I want to believe it’s all earnings blackout related, I know it’s not. There are damn few compelling reasons to buy most stocks at these valuations and insiders know it.  Insiders as a group are value buyers, not index chasers or performance mongers. The modest decline of September has almost been completely released by the relief rally … Read more

The Bold, the Inexplicable and the Good Soldiers- Insider Buying Week 9-17-21

by

For trade, details click on this link to the trades.  There were quite a few buys last week and it took me longer than usual to update it. Also, I will provide a brief recap of the conversation I had with the Chief Medical Officer, Alexander A. Zukiwski at Casi Pharmaceuticals. Casi is a U.S. NASDAQ-listed biotech selling exclusively to the increasingly affluent Chinese middle class.  CASI is a penny stock that will turn into $dollars if things pan out the way I think. They have one approved revenue-producing product with an exciting pipeline. There is a high probability they … Read more